The Nasal Packing Devices Market is anticipated to be valued at USD 209.2 million in 2025 and is expected to reach USD 337.5 million by 2035, registering a CAGR of 4.9%.
| Metric | Value |
|---|---|
| Market Size in 2025 | USD 209.2 Million |
| Projected Market Size in 2035 | USD 337.5 Million |
| CAGR (2025 to 2035) | 4.9% |
This market is experiencing significant growth, propelled by the increasing prevalence of chronic sinusitis, epistaxis, and the rising number of ENT surgeries. Advancements in bioresorbable materials and patient-friendly designs are enhancing postoperative care, leading to broader adoption in both hospital and outpatient settings. The shift towards minimally invasive procedures and the emphasis on patient comfort are further driving demand. Manufacturers are focusing on developing absorbable, antimicrobial, and drug-eluting nasal packs to reduce complications and improve healing outcomes.
The market is also benefiting from the expansion of healthcare infrastructure in emerging economies, coupled with increased awareness of nasal health. These factors collectively contribute to a positive outlook for the market, with sustained growth anticipated in the coming years.
Prominent players in the Nasal Packing Devices Market include Medtronic, Smith & Nephew, Stryker, Summit Medical, and Lohmann & Rauscher. These companies are at the forefront of innovation, focusing on developing advanced nasal packing solutions that enhance patient comfort and clinical outcomes. Key activities influencing market growth encompass the introduction of bioresorbable materials, antimicrobial coatings, and drug-eluting technologies.
In Oct 2024, Aptar Pharma, announces that it has acquired all device technology assets from the proprietary portfolio of SipNose Nasal Delivery Systems, a company focused on intranasal delivery platforms for local, systemic and central nervous system indications.
“Our nasal systems’ proven capabilities have brought added value to our customers and further convenience for patients worldwide for over 30 years, As the nasal market looks to develop new drugs to address unmet patient needs, this transaction will enhance Aptar’s portfolio of nasal drug delivery systems with a focus on CNS diseases.” Said Alex Theodorakis, President Aptar Pharma Prescription.
The gel-based product segment has emerged as the market leader, capturing 52.4% revenue share in 2025, owing to its enhanced usability and patient-centric features. This segment has been favored due to its ability to provide superior hemostasis, effective mucosal adhesion, and minimal post-operative trauma.
Unlike traditional packs, gels reduce the risk of tissue damage upon removal and significantly improve patient compliance. The segment’s growth has also been driven by the rising number of ENT procedures, wherein clinicians prefer gel formulations for ease of application and improved outcomes.
Additionally, clinically documented evidence from ENT specialists and surgical practitioners has validated the efficacy of gel nasal packing in managing epistaxis and post-surgical bleeding. Increased R&D investments by medical device manufacturers have resulted in formulations that offer biocompatibility, sustained drug release, and resorbability, further enhancing its appeal. The integration of antimicrobial agents into gel compositions has also contributed to its widespread acceptance, particularly in outpatient and minimally invasive settings.
The non-absorbable segment accounts for the largest share of 55.2% in the nasal packing devices market in 2025, largely attributed to its affordability, availability, and reusability in clinical practice. This segment has remained dominant due to strong acceptance in hospital and surgical settings, where precision and post-surgical inspection are critical. Surgeons have continued to prefer non-absorbable packs for their structural integrity, which ensures effective nasal cavity support during the healing phase.
Furthermore, non-absorbable materials, typically composed of polyvinyl alcohol (PVA) and silicone-based compounds, have demonstrated high tolerance and minimal adverse reactions. Their predictable performance in preventing post-operative adhesion and maintaining septal alignment has sustained demand.
In cost-sensitive healthcare systems, especially in developing regions, these devices offer a favorable price-performance ratio, further driving adoption. Although bioresorbable alternatives are growing, the familiarity among ENT professionals, coupled with ease of removal and strong clinical outcomes, has reinforced the position of non-absorbable materials as the preferred choice for many procedural workflows.
Patient Discomfort, Risk of Adhesion, and Limited Reimbursement
Nasal packing devices market is still ongoing challenges related to patient discomfort, especially due to rigid or non-absorbable nasal packs that result in pain, mucosal injury, or synechiae formation upon removal. Moreover, factors like no standardized regimens for post-operative care and the heterogeneity in ENT surgical techniques further exasperate both product choice and clinician uptake.
Lack of coverage by reimbursement programs, especially for new bioresorbable technologies and in-office practices, is a limitation associated with reforming healthcare systems. Other factors leading to the complication rate include infection risk and user compliance with care after packaging.
Bioabsorbable Materials, Minimally Invasive ENT Procedures, and Outpatient Expansion
Combined with these disadvantages, the industry is positioned to expand by means of improvements to bioabsorbablehemostatic nose packing gadgets available with less patient distress, antimicrobial features, and don't require removal. Novel chitosan-based sponges, hyaluronic acid-releasing tampons, and shape-memory foam are among those improving clinical outcomes after surgery (septoplasty, FESS, turbinate reduction).
The growth of day-care ENT procedures, wider application of nasal endoscopes, and broader use of ambulatory surgical centers (ASCs) provide new platforms for growth. Other trends such as the incidence of sinusitis, nasal trauma, and cosmetic rhinoplasties drive procedural volumes globally.
The United States nasal packing devices market is entering in a very rapid growth phase by predominately supported with the growing prevalence of epistaxis (nosebleeds) among the population, rise in ENT procedures and high rate of chronic sinusitis and nasal surgeries.
Growing population base with the need for ENT specialists and better access to these specialists results in an increase in demand for absorbable and non-absorbable nasal packing solutions. Technology is making product lines richer with drug-eluting, biodegradable, hemostatic. In addition, rising patient volume of outpatient ENT procedures is propelling adoption of easy-to-use nasal packing kits in ambulatory facilities.
| Country | CAGR (2025 to 2035) |
|---|---|
| USA | 5.2% |
The UK nasal packing devices market has moderate growth owing to NHS uptake of minimally invasive ENT procedures and growing application of nasal packing in trauma care and elective nasal surgeries.
Increasing awareness of post- operative care and rising usage of absorbable nasal packs in sinus and septoplasty therapies propel the market growth. Also, clinician preference for devices that are low-irritation and antimicrobial-coated is becoming a factor in hospital purchasing decisions.
| Country | CAGR (2025 to 2035) |
|---|---|
| UK | 4.7% |
Germany, France and Netherlands have developed otolaryngology practice in these countries and a rising trend towards growth in the EU Nasal Packing Devices market. Additionally, major application segments are about ENT procedures, supported by chronic rhinitis, deviated septum, and nasal polyps.
Several packing manufacturers are ensuring compliance with stringent regulations under MDR to promote adoption of biocompatible and CE-marked packing materials. Instead of gauze, clinics and hospitals are choosing packing devices that are comfort-based, anti-adhesion and bioabsorbable to reduce the need for follow-ups.
| Region | CAGR (2025 to 2035) |
|---|---|
| EU | 4.6% |
The Japan nasal packing devices market is gaining steady momentum due to increasing adoption of ENT surgeries by its elderly people along with rising awareness regarding minimally invasive treatment procedures.
Japanese healthcare units prefer small, high absorption, and painless removal penetrable nasal packs. Domestic companies are seeking antimicrobial or anti-inflammatory coated versions that promote post-surgical recovery and patient comfort.
| Country | CAGR (2025 to 2035) |
|---|---|
| Japan | 4.9% |
In South Korea, the nasal packing devices market is booming, owing to the amalgamation of aesthetic nasal surgeries (like rhinoplasty), a prevalence of allergic rhinitis, and fast-paced healthcare modernization.
Increasing use of advanced, sponge based and biodegradable nasal packing systems in ENT clinics and tertiary care hospitals. Local manufacturing of affordable and innovative nasal packs is also strengthening the domestic supply chain of the country.
| Country | CAGR (2025 to 2035) |
|---|---|
| South Korea | 5.0% |
The global nasal packing devices market is anticipated to be driven by growing prevalence of nasal surgeries (septoplasty, FESS), epistaxis (nosebleed), and sinusitis. Nasal packing devices are used to control bleeding, stabilize the nasal cavity, prevent adhesions, and improve healing after surgery.
The factors contributing to this rise in market growth include growing ENT procedures, increasing demand for absorbable and biocompatible materials, innovations in hemostatic agent technology, and expanding outpatient ENT clinics.
The market is segmented into Injectable, Gel, Spray, and Dressings.
The market is segmented into Bio-Resorbable and Non-Absorbable.
The Nasal Packing Devices Market is analyzed across North America, Latin America, East Asia, South Asia & Pacific, Eastern Europe, Western Europe, and the Middle East & Africa.
The overall market size for nasal packing devices market was USD 209.2 million in 2025.
The nasal packing devices market is expected to reach USD 337.5 million in 2035.
Increasing cases of chronic sinusitis and nasal surgeries, rising preference for minimally invasive ENT procedures, and growing use of absorbable nasal packing materials will drive market growth.
The top 5 countries which drives the development of nasal packing devices market are USA, European Union, Japan, South Korea and UK.
Bio-resorbable expected to grow to command significant share over the assessment period.
Explore Similar Insights
Nasal Packing Devices Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
